We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

171 hedge funds and large institutions have $1.44B invested in Imperva, Inc. in 2017 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 51 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $12.3M | Put options by funds: $8.03M

31% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 51

6% less funds holding

Funds holding: 181171 (-10)

7% less capital invested

Capital invested by funds: $1.55B → $1.44B (-$108M)

23% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 35

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
171
Holders Change
-10
Holders Change %
-5.52%
% of All Funds
4.26%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
27
Increased
67
Reduced
51
Closed
35
Calls
$12.3M
Puts
$8.03M
Net Calls
+$4.29M
Net Calls Change
-$15.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity International
26
Fidelity International
Bermuda
$12.2M
Goldman Sachs
27
Goldman Sachs
New York
$12M -$19.8M -434,805 -61%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$11.9M +$2.98M +65,407 +31%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$11.7M +$565K +12,388 +5%
ECP
30
Elk Creek Partners
Colorado
$11.7M +$2.84M +62,330 +30%
SIMG
31
Stephens Investment Management Group
Texas
$11M +$1.2M +26,262 +12%
1M
32
13D Management
New York
$10.9M +$1.17M +25,595 +11%
Morgan Stanley
33
Morgan Stanley
New York
$10.5M -$7.45M -163,161 -40%
First Trust Advisors
34
First Trust Advisors
Illinois
$10.3M +$3.46M +75,913 +47%
GES
35
GO ETF Solutions
United Kingdom
$9.35M -$606K -13,271 -6%
Wells Fargo
36
Wells Fargo
California
$9.29M +$1.04M +22,741 +12%
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$8.87M -$13.5K -296 -0.1%
TCIM
38
TIAA CREF Investment Management
New York
$8.39M +$957K +20,970 +12%
Fuller & Thaler Asset Management
39
Fuller & Thaler Asset Management
California
$7.84M -$77.6K -1,700 -0.9%
PAM
40
Panagora Asset Management
Massachusetts
$7.79M +$8.17M +179,072 +43,783%
Bank of Nova Scotia
41
Bank of Nova Scotia
Ontario, Canada
$7.59M
BA
42
Broadview Advisors
Wisconsin
$7.09M +$58.2K +1,275 +0.8%
Fisher Asset Management
43
Fisher Asset Management
Washington
$7M -$554K -12,149 -7%
Two Sigma Investments
44
Two Sigma Investments
New York
$6.97M -$8.02M -175,688 -52%
American Century Companies
45
American Century Companies
Missouri
$6.83M +$7.18M +157,419 New
Bank of New York Mellon
46
Bank of New York Mellon
New York
$6.54M +$672K +14,727 +11%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$6.5M
LCM
48
Laurion Capital Management
New York
$6.3M +$6.62M +145,100 New
Charles Schwab
49
Charles Schwab
California
$6.02M +$312K +6,842 +5%
SFM
50
Soros Fund Management
New York
$5.5M +$5.78M +126,666 New

IMPV Hedge Fund Activity: Q3 2017 in Review

171 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q3 2017, worth a combined $1.44B — down 7% from $1.55B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of IMPV and 27 opened new positions — a net loss of 8 holders — while 51 trimmed existing stakes and 67 added.

The largest buyer was BlackRock, adding an estimated $28.2M. The largest seller was Citadel Advisors, cutting an estimated $27.4M.

  • 171 institutional investors held Imperva, Inc. (IMPV) as of Q3 2017, down from 181 in Q2 2017.
  • Funds reported $1.44B of Imperva, Inc. stock for Q3 2017, down 7% quarter-over-quarter.
  • 27 funds opened new Imperva, Inc. positions in Q3 2017 and 35 closed out, a net change of -8 holders.
  • The largest Imperva, Inc. buyer in Q3 2017 was BlackRock, an estimated $28.2M added.
  • The largest Imperva, Inc. seller in Q3 2017 was Citadel Advisors, an estimated $27.4M sold.

Based on aggregated 13F filings for Q3 2017.